Founder, CEO | Founding Director (board)

Enabling better scientific outcomes through novel photonics tools.
ORYL’s mission is to establish a new reference standard for solubility and aggregation measurement in the pharmaceutical industry. We aim to deliver results that are trustworthy, reproducible, and robust — enabling pharma R&D teams to make better decisions, faster.
The name ORYL carries dual meaning: “my light” in Hebrew and “eagle” in Slavic — symbols of clarity and vision that reflect our ambition to bring transformative impact to drug discovery and development.

We collaborate with partners across pharma, biotech, and academia.








If it is not simple enough, it must be wrong. We strive for clarity and efficiency in everything we build and communicate.
We are biased towards execution and speed. We learn, adapt, and respond to the needs of our customers and the market.
We do what we say. Our instruments, our data, and our promises are robust and dependable.
We love what we do. We care deeply about our impact on the world and the science we enable.
ORYL’s culture is a combination of all of us. We work collaboratively, supportively, critically but respectfully.
A team of scientists, engineers, and business leaders united by a shared passion for better science.

Orly Tarun, Ph.D
Founder, CEO | Founding Director (board)

Kaspar Cottier, Ph.D
R&D at ORYL | Investor Director (Board)

Louis Dumas
Head of Applications

David Roesel, Ph.D
Head of Software Development

Aristea Massaras
Laboratory Manager

Bernhard Fuchs
Strategic Finance Support















We are building a company that brings together science, engineering, and impact. If you share our values and want to help establish a new reference standard in pharmaceutical measurement, we’d like to hear from you.
We’d be happy to tell you about our technology, our team, and our vision.